The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Podzolkova N.M.

Kafedra akusherstva i ginekologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Shamugia N.L.

IVF&
Genetics Center «FertiMed», Moscow, Russia ,Department of endocrinology of postgraduated medical faculty of RUPF, Moscow, Russia

Borisova M.S.

Russian medical academy for continuous professional education, Moscow, Russia

Anshina M.B.

Tsentr reproduktsii i genetiki "FertiMed", Moskva

Comparison of the effectiveness of various stimulation protocols in patients with reduced ovarian reserve

Authors:

Podzolkova N.M., Shamugia N.L., Borisova M.S., Anshina M.B.

More about the authors

Journal: Russian Journal of Human Reproduction. 2019;25(3): 91‑98

Read: 2716 times


To cite this article:

Podzolkova NM, Shamugia NL, Borisova MS, Anshina MB. Comparison of the effectiveness of various stimulation protocols in patients with reduced ovarian reserve. Russian Journal of Human Reproduction. 2019;25(3):91‑98. (In Russ.)
https://doi.org/10.17116/repro20192503191

Recommended articles:
The role of ferroptosis in reproduction. A modern view of the problem. Russian Journal of Human Reproduction. 2024;(5):35-45
The expe­rience of using the nasal form of GnRH agonists in in vitro fertilization programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):79-84
Comparison of the main methods of surgical treatment of patients with colo­rectal endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):118-123

References:

  1. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertility and Sterility. 2011;96(5):1058-1061. https://doi.org/10.1016/j.fertnstert.2011.09.048
  2. Patrizio P, Vaiarelli A, Levi Setti PE, Tobler KJ, Shoham G, Leong M, Shoham Z. How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. Reproductive BioMedicine Online. 2015;30(6):581-592. https://doi.org/10.1016/j.rbmo.2015.03.002
  3. Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor? A systematic review. Human Reproduction Update. 2012;(18):1-11. https://doi.org/10.1093/humupd/dmr037
  4. Mohamed AA, Al-Hussaini TK, Fathalla MM, El Shamy TT, Abdelaal II, Amer SA. The impact of excision of benign nonendometriotic ovarian cysts on ovarian reserve: a systematic review. American Journal of Obstetrics and Gynecology. 2016;215(2):169-176. https://doi.org/10.1016/j.ajog.2016.03.045
  5. Zhang W, Ding L, Tang R, Sheng Y, Qin YY, Chen ZJ. Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle. Chinese Journal of Obstetrics and Gynecology. 2016;51(3):180-185. https://doi.org/10.3760/cma.j.issn.0529-567X.2016.03.004
  6. Hwu YM, Wu FS, Li SH, Sun FJ, Lin MH, Lee RK. The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels. Archives of Gynecology and Obstetrics. 2016;293:1049-1052. https://doi.org/10.1007/s00404-015-3926-4
  7. Biacchiardi CP, Piane LD, Camanni M, Deltetto F, Delpiano EM, Marchino GL, Gennarelli G, Revelli A. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reproductive BioMedicine Online. 2011;23(6):740-746. https://doi.org/10.1016/j.rbmo.2011.07.014
  8. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and metaanalysis. The Journal of Clinical Endocrinology and Metabolism. 2012;97(9):3146-3154. https://doi.org/10.1210/jc.2012-1558
  9. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertility and Sterility. 2012;98(6):1531-1538. https://doi.org/10.1016/j.fertnstert.2012.08.009
  10. Vignali M, Mabrouk M, Ciocca E, Alabiso G, Barbasetti di Prun A, Gentilini D, Busacca M. Surgical excision of ovarian endometriomas: Does it truly impair ovarian reserve? Long term anti-Müllerian hormone (AMH) changes after surgery. Journal of Obstetrics and Gynaecology Research. 2015;41(11):1773-1778. https://doi.org/10.1111/jog.12830
  11. Sugita A, Iwase A, Goto M, Nakahara T, Nakamura T, Kondo M, Kikkawa F. One-year follow-up of serum anti-Müllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? Fertility and Sterility. 2013;100(2):516-522. https://doi.org/10.1016/j.fertnstert.2013.03.032
  12. Adamyan LV, Kurilo LF, Shulyak IYu. Ovarian folliculogenesis in women with some forms of endometriosis. Problemy reproduktsii. 2009;15(1):78-85 (In. Russ.).
  13. Kitajima M, Dolmans MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertility and Sterility. 2014;101(4):1031-1037. https://doi.org/10.1016/j.fertnstert.2013.12.049
  14. Wu G, Bersinger NA, Mueller MD, von Wolff M. Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis. Journal of Assisted Reproduction and Genetics. 2017;34(3):357-364. https://doi.org/10.1007/s10815-016-0865-3
  15. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and metaanalysis. Human Reproduction Update. 2015;21(6):809-825. https://doi.org/10.1093/humupd/dmv035
  16. Demirol A, Guven S, Baykal C, Gurgan T. Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study. Reproductive BioMedicine Online. 2006;12(5):639-643. https://doi.org/10.1016/S1472-6483(10)61192-3
  17. Yazbeck C, Madelenat P, Sifer C, Hazout A, Poncelet C. Ovarian endometriomas: Effect of laparoscopic cystectomy on ovarian response in IVF-ET cycles. Gynécologie Obstétrique and Fertilité. 2006;34(9):808-812. https://doi.org/10.1016/j.gyobfe.2006.07.003
  18. Bongioanni F, Revelli A, Gennarelli G, Guidetti D, Delle Piane L, Holte J. Ovarian endometriomas and IVF: a retrospective case-control study. Reproductive Biology and Endocrinology. 2011;9(1):81. https://doi.org/10.1186/1477-7827-9-81
  19. González-Comadran M, Schwarze JE, Zegers-Hochschild F, Souza M do CB, Carreras R, Checa MÁ. The impact of endometriosis on the outcome of Assisted Reproductive Technology. Reproductive Biology and Endocrinology. 2017;15(1):8. https://doi.org/10.1186/s12958-016-0217-2
  20. Xu B, Guo N, Zhang XM, Shi W, Tong XH, Iqbal F, Liu YS. Oocyte quality is decreased in women with minimal or mild endometriosis. Scientific Reports. 2015;5(1):10779. https://doi.org/10.1038/srep10779
  21. Barnhart K, Rebecca Dunsmoor-Su, Christos Coutifaris. Effect of endometriosis on in vitro fertilization. Fertility and Sterility. 2002;77(6):1148-1155. https://doi.org/10.1016/S0015-0282(02)03112-6
  22. Somigliana E, Arnoldi M, Benaglia L, Iemmello R, Nicolosi AE, Ragni G. IVF-ICSI outcome in women operated on for bilateral endometriomas. Human Reproduction. 2008;23(7):1526-1530. https://doi.org/10.1093/humrep/den133
  23. Barbosa MAP, Teixeira DM, Navarro PA, Ferriani RA, Nastri CO, Martins WP. Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and metaanalysis. Ultrasound in Obstetrics and Gynecology. 2014;44(3):261-278. https://doi.org/10.1002/uog.13366
  24. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Human Reproduction. 2011;26(7):1768-1774. https://doi.org/10.1093/humrep/der106
  25. Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Human Reproduction. 2013;28(10):2728-2734. https://doi.org/10.1093/humrep/det303
  26. Simoni M, Santi D, Negri L, Hoffmann I, Muratori M, Baldi E, Cambi M, Marcou M, Greither T, Baraldi E, Tagliavini S, Carra D, Lombardo F, Gandini L, Pallotti F, Krausz C, Rastrelli G, Ferlin A, Menegazzo M, Pignatti E, Linari F, Marino M, Benaglia R, Levi-Setti PE, Behre HM. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. Human Reproduction. 2016;31(9):1960-1969. https://doi.org/10.1093/humrep/dew167
  27. Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Human Reproduction. 2016;31(2):370-376. https://doi.org/10.1093/humrep/dev316
  28. Ferraretti AP, Marca ALa, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L; on behalf of the ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction. 2011;26(7):1616-1624. https://doi.org/10.1093/humrep/der092
  29. Younis JS, Ben-Ami M, Ben-Shlomo I. The Bologna criteria for poor ovarian response: a contemporary critical appraisal. Journal of Ovarian Research. 2015;8:76. https://doi.org/10.1186/s13048-015-0204-9
  30. Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON Criteria — the why. Frontiers in Endocrinology. 2018;9:461. https://doi.org/10.3389/fendo.2018.00461
  31. Ke H, Chen X, Liu YD, Ye DS, He YX, Chen SL. J. Cumulative live birth rate after three ovarian stimulation IVF cycles for poor ovarian responders according to the bologna criteria. Journal of Huazhong University of Science and Technology. 2013;33(3):418-422. https://doi.org/10.1007/s11596-013-1134-7
  32. Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reproductive BioMedicine Online. 2018;36(4):435-441. https://doi.org/10.1016/j.rbmo.2018.01.008
  33. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update. 2010,16(2):113-130. https://doi.org/10.1093/humupd/dmp036
  34. Gallot V, Berwanger da Silva AL, Genro V, Grynberg M, Frydman N, Fanchin R. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Human Reproduction. 2012;27(4):1066-1072. https://doi.org/10.1093/humrep/der479
  35. Poseidon Group: Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Humaidan P. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertility and Sterility. 2016;105(6):1452-1453. https://doi.org/10.1016/j.fertnstert.2016.02.005
  36. Surrey ES. Management of the poor responder: the role of GnRH agonists and antagonists. Journal of Assisted Reproduction and Genetics. 2007;24(12):613-619. https://doi.org/10.1007/s10815-007-9180-3
  37. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose gnrh agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertility and Sterility. 1998:69(3): 419-424. https://doi.org/10.1016/S0015-0282(97)00575-X
  38. Detti L, Williams DB, Robins JC, Maxwell RA, Thomas MA. A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization. Fertility and Sterility. 2005;84(5):1401-1405. https://doi.org/10.1016/j.fertnstert.2005.04.053
  39. Chen YM, Qi QR, Xie QZ, Yang YF, Xia Y, Zhou XD. Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study. Current Medical Science. 2018;38(3):513-518. https://doi.org/10.3109/09513590.2014.906570
  40. Davar R, Neghab N, Naghshineh E. Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF/ICSI: An RCT. International Journal of Reproductive Biomedicine. 2018;16(4):255-260. https://doi.org/10.29252/ijrm.16.4.260
  41. Berkkanoglu M, Ozgur K. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertility and Sterility. 2010;94(2):662-665. https://doi.org/10.1016/j.fertnstert.2009.03.027
  42. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertility and Sterility. 2015;104(5):1145-1152. https://doi.org/10.1016/j.fertnstert.2015.07.1151
  43. Humaidan P, Chin W, Rogoff D, D’Hooghe T, Longobardi S, Hubbard J, Schertz J, on behalf of the ESPART Study Investigators. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Human Reproduction. 2017;32(3):544-555. https://doi.org/10.1093/humrep/dew360
  44. Huang P, Tang M, Qin A. Progestin primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: A retrospective study. Journal of Gynecology Obstetrics and Human Reproduction. 2019;48(2):99-102. https://doi.org/10.1016/j.jogoh.2018.10.008
  45. Labarta E, Marin D, Remohí J, Bosch E. Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria. Reproductive BioMedicine Online. 2018;37(4):434-441. https://doi.org/10.1016/j.rbmo.2018.07.007
  46. Song D, Shi Y, Zhong Y, Meng Q, Hou S, Li H. Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\ICSI procedures: a metaanalysis. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2016;204:36-43. https://doi.org/10.1016/j.ejogrb.2016.07.498
  47. Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertility and Sterility. 2004;82:1561-1563. https://doi.org/10.1016/j.fertnstert.2004.04.070
  48. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Human Reproduction. 2004;19(9):2031-2035. https://doi.org/10.1093/humrep/deh359
  49. Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertility and Sterility. 2003;80(1):116-122. https://doi.org/10.1016/S0015-0282(03)00544-2
  50. Mikolajczyk RT, Frank-Herrmann P, Freundl G, Stanford JB. More than one fertile ovulation per cycle? Fertility and Sterility. 2004;81(3):728-729. https://doi.org/10.1016/j.fertnstert.2003.11.016
  51. Baird DD. More than one fertile ovulation per cycle? Fertility and Sterility. 2004;81(3):729. https://doi.org/10.1016/j.fertnstert.2003.12.003
  52. Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reproductive BioMedicine Online. 2014;29(6):684-691. https://doi.org/10.1016/j.rbmo.2014.08.009
  53. Ubaldi FM, Capalbo A, Vaiarelli A, Cimadomo D, Colamaria S, Alviggi C, Rienzi L. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertility and Sterility. 2016;105(6):1488-1495. https://doi.org/10.1016/j.fertnstert.2016.03.002
  54. Vaiarelli A, Cimadomo D, Trabucco E, Vallefuoco R, Buffo L, Dusi L, Ubaldi FM. Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. Frontiers in Endocrinology. 2018;9:317. https://doi.org/10.3389/fendo.2018.00317
  55. Roque M, Bianco B, Christofolini DM, Barchi Cordts E, Vilarino F, Carvalho W, Valle M, Sampaio M, Geber S, Esteves SC, Parente Barbosa C. Pharmacogenetic algorithm for individualized controlled ovarian stimulation (iCOS) in assisted reproductive technology cycles. Panminerva Medica. 2019;61(1):76-81. https://doi.org/10.23736/S0031-0808.18.03496-1
  56. Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome. Human Reproduction. 2015;30(4):840-847. https://doi.org/10.1093/humrep/dev029
  57. Hong SB, Lee NR, Kim SK, Kim H, Jee BC, Suh CS, Kim SH, Choi YM. In vitro fertilization outcomes in women with surgery induced diminished ovarian reserve after endometrioma operation: Comparison with diminished ovarian reserve without ovarian surgery. Obstetrics and Gynecology Science. 2017;60(1):63-68. https://doi.org/10.5468/ogs.2017.60.1.63

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.